Replies to post #754153 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

But there is no suggestion that this additional business takes precedence over DCVax-L manufacturing. The company's not anywhere near capacity, and yes, the rental income and inexpensive development funds are good additional subsidies that most companies would never have.

There is also no suggestion that DCVax-L takes precedence over the additional business. We don’t know.

We also don’t have a lot of concrete information about capacity.

So what is the rental income that NWBO is getting?